Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?

The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndrome

(2014) Samuel A. Yousem et al.   HUMAN PATHOLOGY

Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus

(2014) Hayakazu Sumida et al.   JOURNAL OF DERMATOLOGY

Fibrosis—a lethal component of systemic sclerosis

(2014) Yuen Yee Ho et al.   Nature Reviews Rheumatology

Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study

(2014) G. Moroni et al.   RHEUMATOLOGY

Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

(2013) Tünde Minier et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity

(2013) M E Doorenspleet et al.   ANNALS OF THE RHEUMATIC DISEASES

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Rituximab in severe, treatment-refractory interstitial lung disease

(2013) Gregory J. Keir et al.   RESPIROLOGY

Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?

(2013) S. Cappelli et al.   RHEUMATOLOGY

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis

(2013) Antoine François et al.   ARTHRITIS RESEARCH & THERAPY

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

(2013) Francesco Carubbi et al.   ARTHRITIS RESEARCH & THERAPY

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

(2012) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Diagnosis and management of chronic graft-versus-host disease

(2012) Fiona L. Dignan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Two-year Results of an Open Pilot Study of a 2-treatment Course with Rituximab in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement

(2012) V. SMITH et al.   JOURNAL OF RHEUMATOLOGY

American College of Rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort

(2012) S. C. Shiboski et al.   ARTHRITIS CARE & RESEARCH

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort

(2012) Mandana Nikpour et al.   ARTHRITIS RESEARCH & THERAPY

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin

(2012) Dimitrios Daoussis et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis

(2011) David B. Clifford   ARCHIVES OF NEUROLOGY

Molecular signature of a public clonotypic autoantibody in primary Sjögren's syndrome: A “forbidden” clone in systemic autoimmunity

(2011) Rhianna Lindop et al.   ARTHRITIS AND RHEUMATISM

Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis

(2011) C. A. Langford   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Immunosuppressive effect of cyclophosphamide on white blood cells and lymphocyte subpopulations from peripheral blood of Balb/c mice

(2011) Xiao-Hui Huyan et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)

(2011) JT Merrill et al.   LUPUS

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

(2010) G. Riemekasten et al.   ANNALS OF THE RHEUMATIC DISEASES

V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis

(2010) Tobias Scheel et al.   ARTHRITIS AND RHEUMATISM

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

B cell lymphoproliferation and organ-directed self-recognition to explain autoimmunity: Back to the past

(2010) Fiona McQueen et al.   MEDICAL HYPOTHESES

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

(2010) Silvia Bosello et al.   ARTHRITIS RESEARCH & THERAPY

Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis

(2009) Consuelo M. López De Padilla et al.   ARTHRITIS AND RHEUMATISM

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

(2009) Robert Lafyatis et al.   ARTHRITIS AND RHEUMATISM

Rituximab treatment of the anti-synthetase syndrome—a retrospective case series

(2009) Marthe Sem et al.   RHEUMATOLOGY

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

(2009) Dimitrios Daoussis et al.   RHEUMATOLOGY

Data Sources for Improving Estimates of the Global Burden of Injuries: Call for Contributors

(2009) Kavi Bhalla et al.   PLOS MEDICINE

CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma

(2008) Ayumi Yoshizaki et al.   AMERICAN JOURNAL OF PATHOLOGY

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

(2008) V Smith et al.   ANNALS OF THE RHEUMATIC DISEASES

Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease

(2008) N Dalbeth et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

(2008) E Keystone et al.   ANNALS OF THE RHEUMATIC DISEASES

CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model

(2008) Kazuhiro Komura et al.   ARTHRITIS AND RHEUMATISM

Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease

(2007) J.B. Kim et al.   Journal of Plastic Reconstructive and Aesthetic Surgery